glp-1 alzheimer's study Frontiers GLP-1 Drug Fails to Quell
Description
Commercially insured patients show a similar trend: 36% who began GLP-1 therapy in 2024 did not add another drug within a year, a significant rise from 13% in 2020
Her limb volume difference dropped from 10.3% down to 3.4% and she no longer required a compression garment
doi: 10.3390/nu11122949
Anbazhagan AN, Thaqi M, Priyamvada S, Jayawardena D, Kumar A, Gujral T et al
